Microsurgery News
-
Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared Fluorescence Visualization, Expanding Application of Existing Robotic Exoscope
Near-Infrared fluorescence now available on Modus X robotic exoscope, complementing system’s existing advanced fluorescence capabilities New Infrared fluorescence enables the use of Modus X for visualization of vessels in conjunction with indocyanine green New patented 4K ICG Image Fusion for real-time contrast of microsurgical vessels against background anatomy Synaptive Medical ...
-
Australian Medical Micro Screw Innovation Makes World Debut in 30 Jan 2019 Brisbane Operation
An innovative Australian micro screw created to help significantly reduce complications in the management of orthopaedic injuries and the fixing of fractures in the hand and wrist will be used in a world-first operation in Brisbane by internationally-renowned hand surgeon Dr Greg Couzens on Wednesday 30 January. The Field Micro Screw by Brisbane med-tech start-up Field Orthopaedics has already ...
-
A new member joins our Medical Advisory Board
We would like to announce that Dr. Maria Mani is our newest member of our Medical Advisory Board. Maria is an associate professor, senior lecturer and director of the plastic and reconstructive microsurgery department at the Uppsala University Hospital. ...
-
Microsure live at WSRM2022 in Cancun
Microsure will be present at #WSRM2022 in Cancun, Mexico. Come and visit us at booth 8 (1-4 June) to learn about our newest generation microsurgical robot. Update: After a year of absence due to the pandemic, the World Society of Reconstructive Microsurgery could celebrate its 11th Congress in Cancun from 1-4 June 2022. Microsure was present for the second time and provided a sneak ...
-
What is CO2 Fractional Laser Treatment
CO2 fractional laser resurfacing machine treatment can quickly improve skin texture, firm skin, improve large pores, and make skin smooth and tender like water. CO2 fractional laser technology is now the world's leading technology for wrinkle removal and skin rejuvenation. Through pulsed fractional laser, laser beauty has been raised to a new level. Bvlaser is a professional CO2 fractional laser ...
-
What is the principle of HIFU ultrasound machine for relieving aging and firming skin?
HIFU is the abbreviation of high intensity focused ultrasound. It uses focused ultrasound energy to accurately inject the dermis, subcutaneous tissue, and SMAS (facial superficial aponeurotic system) fascia layer of the skin to increase the temperature of the target site and initiate collagen regeneration and firming. There are two keys to HIFU skin tightening machine treatment: depth and ...
-
Medical Microinstruments Introduces Even Smaller Robotic Instruments to Address Complex Supermicrosurgery
Pisa, Italy-September 7, 2022 - Medical Microinstruments. Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its new Supermicro NanoWrist® instruments for use with the Symani® Surgical System, developed specifically to address the challenges of microsurgery. The new supermicro needle holder and ...
-
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
PISA, Italy - July 20, 2022 - Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing. Deerfield Management led the round with participation from new investors, RA Capital Management and Biostar Capital, as well as existing investors, Andera Partners, ...
-
MRE supports collaboration between Microsure and MTA
Metropolitan Region Eindhoven (MRE) provides a stimulus grant to support a new development program between Microsure and MTA. With the funding, MUSA-3, a new generation microsurgical robot will be developed where safety, usability, dexterity and ergonomics will be improved. We are very pleased that with the financial support from the region, our long-standing collaboration can be ...
-
OnLume Surgical Awarded $2 Million Grant from National Cancer Institute to Advance the Development of its Novel Fluorescence-Guided Surgery Device
OnLume Inc., an early stage medical imaging company with unique technology for improving surgical precision, has been awarded a substantial grant from the U.S. National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary device for Fluorescence-Guided Surgery (FGS). OnLume has developed novel FGS imaging technology to illuminate critical ...
By OnLume Inc.
-
OnLume Surgical Participates in Clinical Trial Combining Fluorescence-Guided Surgery Imaging Device with Alume’s Novel Nerve-Targeting Agent
OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start of participation in a clinical trial combining its fluorescence-guided surgery (FGS) imaging device with a novel nerve-targeting agent. OnLume has unique FGS imaging technology to illuminate critical anatomy in real time during ...
By OnLume Inc.
-
Onlume Receives FDA 510(k) Clearance for Fluorescence-guided Surgery Device
OnLume has received 510(k) clearance from the U.S. Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...
By OnLume Inc.
-
World premiere in plastic surgery at Maastricht UMC+
Microsure and Olympus teamed up in the world’s first case in plastic surgery in which robotic microsurgery was combined with their newest digital exoscope. Microsure’s MUSA and the Olympus OrbEye 3D 4K camera were used during a clinical case. With this set-up the surgeon is able to do so-called “heads up microsurgery”, which means the surgeon does not have to look through ...
-
Medical Microinstruments Participates in the “Minimally Invasive Robotic Surgery Systems (TREMIRS)” Project
PISA, Italy. June 8.2022 - Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in "THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS). REFERENCE: CPI-2019-33-1-TRE-14. in the framework of the Line for the Promotion of Innovation from the Demand for the Public ...
-
KLISBio to participate at 2022 IFSSH, IFSHT & FESSH Combined Congress With an abstract presentation on SILKBridge
Milan, Italy (June 1st, 2022) – Today, KLISBio, a MedTech company challenging the status quo in regenerative medicine by leveraging a silk-based multidisciplinary technology platform, announced its attendance to 2022 IFSSH, IFSHT & FESSH Combined Congress organized by the International Federation of Societies for Surgery of the Hand and International Federation of Societies for Hand ...
By KLISBio
-
Medical Microinstruments Launches New Simulator for Robotic Microsurgery
PISA, Italy, May 26,2022 - Medical Microinstruments (MMI) SpA. a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its Symani Surgical System Simulator developed by VirtaMed. The simulator will improve, expand, and digitize the pathways for Symani training as surgeons prepare to expand their microsurgical skills through ...
-
Medical Microinstruments Announces Major Expansion in Pisa, Italy to Support Growth
PISA, Italy, May 18, 2022 - Medical Microinstruments (MMI) SpA. a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the grand opening of its new facility in Pisa, Italy. MMI consolidated locations throughout the Pisa area into a 3,000m2 singular site designed to accommodate company growth. The state-of-the-art facility will serve as ...
-
Glaukos Announces Commencement of Phase 2 Corneal Health Clinical Program for Third-Generation iLink Therapy
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has commenced a Phase 2 clinical program for its third-generationiLink™ therapy designed to treat keratoconus. ...
-
MICROSURE raises Series B funds from investors Innovation Industries Fund, BOM & European Investment Fund
Today, we’re excited to announce our closure of Series B funding round led by Innovation Industries Fund (IIF) and including participation from Brabantse Ontwikkelings Maatschappij (BOM) and European Investment Fund (EIF). “There is an exploding global demand for robotic solutions in surgery to help caregivers harness the power of technology to make faster, better and more affordable ...
-
Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Presbyopia
SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has enrolled the first patient into a Phase 2 clinical trial of GLK-302 for the treatment of presbyopia. GLK-302 is the second investigational ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you